SurGenTec's OsteoFlo hydroputty synthetic bone graft earned 510(k) clearance from the FDA, the medtech company said March 7.
The bone graft has proprietary hydrophilic carriers designed to absorb fluids and is optimized for bone growth, according to a news release. It is supplied in a sterile vial and mixing spatula.
"OsteoFlo HydroPutty, with its ability to absorb autologous blood products and its ease of use, fills a critical gap in the realm of synthetic bone grafts," spine surgeon Ashish Patel, MD, said in the release. "Its unique capability to blend with allograft and flow through small apertures makes it extremely useful when performing both open and minimally invasive surgical procedures."